Greiner Bio-One, a leading technology partner for the diagnostic and pharmaceutical industries, is unveiling the 96 well SensoPlate Plus.

As a microscopy plate with a transparent borosilicate glass bottom and a black cycloolefin frame, SensoPlate Plus was developed especially for use in high-resolution microscopy and fluorescence correlation spectroscopy (FCS).

Microscopic applications such as confocal microscopy and fluorescence correlation spectroscopy are sophisticated methods that can benefit from SensoPlate Plus. Consisting of a black cycloolefin frame, 96 well SensoPlate Plus features an ultra-clear borosilicate 175 ?m cover glass bottom affixed with a low autofluorescence adhesive. Resistant to dimethyl sulfoxide and 70-percent ethanol, SensoPlate Plus is suitable for cell culture use.

The SensoPlate Plus glass bottom microplate offers an optimised geometry to facilitate trouble-free measurements and high resolution imaging. Perimeter well microscopy is significantly enhanced due to a condensed distance between the microplate well and skirt bottom. Circular wells prevent disruptive shadow with the smallest possible meniscus lens, and a slightly enlarged well diameter allows an increased working volume. A perimeter ditch may be filled with liquid to minimise edge effect during lengthy incubations.

96 well SensoPlate Plus glass bottom microplates are featured sterile with cell culture treatment, lid, individually wrapped, 16 per case.

SensoPlate™ Plus is a product line from Greiner Bio-One GmbH.
 

About Greiner Bio-One

Greiner Bio-One GmbH - BioScience Division Greiner Bio-One is specialised in the development, production and distribution of plastic laboratory products. The company is a technology partner for universities, research institutes and the diagnostic, pharmaceutical and biotechnology industries as well. With the BioScience division, Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures, as well as microplates for high-throughput screening, allowing industry and research most rapid and efficient drug screening. Additionally Greiner Bio-One develops innovative biochip technologies for genotyping.

Under the management of Georg Heftberger, Rainer Perneker and Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen

(Baden-Württemberg) controls the whole research and development activities in the product ranges Cell Culture, High-Throughput Screening, Biochips and OEM.

Greiner Bio-One GmbH is a division of Greiner Bio-One International AG, based in Kremsmuenster (Austria). Today Greiner Bio-One International AG generates a turnover of 327 million euros. It has over 1,700 employees and operates globally with 20 subsidiaries and numerous distributors in more than 100 countries

 more about Greiner Bio-One

more news from Greiner Bio-One